Extramural Funding & Training Opportunities

FOA Number: RFA-NR-23-001

Earliest Submission Date: Oct. 22, 2022

Letter of Intent Due: Oct. 22, 2022

Expiration Date: Nov. 22, 2022

This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to accelerate implementation of effective non-opioid interventions for chronic pain management in rural and remote populations. Projects include pragmatic, implementation, or hybrid effectiveness-implementation trials to improve pain management and reduce the use of inappropriate opioid medications. Awards made under this FOA will initially support a milestone-driven, planning phase (UG3) of 1 to 2 years, with possible transition to an implementation phase (UH3) of up to 4 years duration (5 years total for the two phases). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA.
 

The overall goal of this initiative is to support the "real world" implementation of effective interventions to manage pain in rural and remote areas. Results from the trials supported by this funding opportunity announcement (FOA) should inform policy makers, payers, community stakeholders, as well as health care providers and patients in the primary care, emergency department, hospital, home health, or dental settings. This FOA requires that the investigators partner with one or more rural healthcare system(s) to plan and implement the intervention. During the planning phase, investigators must develop an additional one or more community-based partnership(s). Studies may propose to integrate multi-component, bundled, or multi-level interventions that have demonstrated efficacy.
 

Trials will become part of and work with the HEAL Pragmatic and Implementation Studies to Improve the Management of Pain and Reduce Opioid Prescribing (PRISM) Program, which has leveraged the infrastructure of the NIH Pragmatic Trials Collaboratory, previously known as the NIH Health Care Systems (HCS) Research Collaboratory. (See https://rethinkingclinicaltrials.org/.) The PRISM Program has established a Coordinating Center (CC) that is providing national leadership and technical expertise in all aspects of research conducted within the Health Care Systems. Awarded applicants will work with the CC (http://rethinkingclinicaltrials.org/about-nih-collaboratory/) to facilitate further planning and refinement of the proposed study in partnership with healthcare delivery systems.

Open Date: Sept. 10, 2021

Remaining Application Due Dates: Feb. 10, 2023, Oct. 10, 2023, and Feb. 13, 2024

Expires: Feb. 14, 2024

PAR-21-308: Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required) 

This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care.

This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials.

The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase.

Open Date: Sept. 10, 2021

Remaining Application Due Dates: Feb. 10, 2023, Oct. 10, 2023, and Feb. 13, 2024

Expires: Feb. 14, 2024

PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) 

This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions.

The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach.

Applications Due Date: Dec. 1, 2022 for an earliest possible start date of Spring 2023.

Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI).

More information about T32 opportunities at the University of Colorado

Palliative Care Post-Doctoral
Research Fellowship Programs Flyer

Letter of Intent (Required) due by Dec. 19, 2022 @ 5pm ET

Full Applications (Invitation Only) due by March 13, 2023 @ 5pm ET

The HCS Scholars program offers researchers an opportunity to partner with healthcare systems to develop embedded pragmatic clinical trials (ePCTs) focused on improving the care provided to people living with dementia (PLWD) and their care partners (CPs). 

• $120k in direct costs for 12 months

The HCS Scholars Program funds a researcher to partner with a HCS (or organization) for 12 months to:

1. Develop relationships between the researcher and HCS staff at all levels, from direct care to leaders.
2. Learn about the HCS: about staff-identified needs for PLWD and CPs; about systems, workflow, and data; and about how HCS implement programs.
3. Engage HCS staff in exploring ways to improve and/or evaluate dementia care and in learning more about what it means to conduct ePCTs in their setting(s).
4. Co-develop a research proposal for an IMPACT Pilot or Demonstration project (or other similar NIA funding mechanism) to improve the care of PLWD and CP.

For more information click HERE

For eligibility and program-related questions, please contact Rachel Hays, Project Manager, IMPACT Health Care Systems Core at Rachel.J.Hays@kp.org

Application Due Date: Feb. 1 of desired start year

Candidates will be selected on a rolling basis each year until each of the 2 new slots per year are filled.

This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The  Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults.

Please see the links below for more information:

• Behavioral Geriatrics T32 Flyer

• T32 Program Information

• Translational Research Institute for Pain in Later Life (TRIPLL)

• Weill Cornell Medical Center for Research on End-of-Life Care

Letter of Intent (LOI) due by Feb. 27, 2023 @ 12pm PT

Full Proposal Grant Application due by June 5, 2023 @ 12pm PT

If invited for an interview, applicant must be available to attend a virtual interview scheduled for Sept. 19 and 20, 2023.

The 2023 Sojourns Scholar Leadership Program call for applications will be the tenth and final cohort.

Each Sojourns Scholar will receive $180k in funding ($90k/year over a 2-year period) to conduct an innovative and impactful clinical, policy, education, or systems change project in the field of palliative care. Emerging palliative care leaders throughout the country, across all disciplines and practice settings, are encouraged to apply.

For more information click HERE

Cambia Palliative Care Center of Excellence: Palliative Care Research Fellowship Program (T32) - UW Medicine

Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung, or blood disease. Funded by a T32 training grant award from NHLBI.

For more details and information about the Palliative Care Research Fellowship, please visit: http://www.uwpalliativecarecenter.com
or email pallcntr@uw.edu